Meharry Report Shows $14T Cost Of US Mental Health Inequities
15 May 2024 //
BUSINESSWIRE
Otsuka backs Bradley Cooper-produced doc film about caregivers
09 May 2024 //
FIERCE PHARMA
Otsuka: Lead Sponsorship of PBS, WETA Caregiving Documentary
08 May 2024 //
BUSINESSWIRE
Justices Pass on Otsuka Judgment in Abilify Warning Case
16 May 2022 //
BLOOMBERG LAW
Otsuka & NEXUS: Moving People From Hopeless to Hopeful
27 Sep 2021 //
FIERCEPHARMA
Otsuka America Pharmaceutical, Inc., Earns Designation as a Great Place to Work
29 Sep 2020 //
BUSINESSWIRE
Otsuka America Pharmaceutical. Provides Eligible, Newly Uninsured Patients
10 Apr 2020 //
BIOSPACE
Lundbeck & Otsuka`s Antipsychotic Drug Fails Two Bipolar Phase III Trials
15 Feb 2019 //
BIOSPACE
Arvelle Acquires Exclusive Rights from SK Biopharmaceuticals` to Develop and Commercialize Cenobamate in EU
13 Feb 2019 //
BUSINESSWIRE
Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial
01 Dec 2018 //
FIERCE BIOTECH
Otsuka Pharma`s Rxulti(brexpiprazole) Receives Approval in Europe
27 Nov 2018 //
EMA
Daliresp (Roflumilast) : AstraZeneca vs. Alkem
24 Nov 2018 //
PATENT LITIGATION
Otsuka Pharmaceutical Development & Commercialization Hosts Roundtable
16 Nov 2018 //
PR NEWSWIRE
Otsuka Pharmaceutical`s Samsca (tolvaptan) Receives Approval in Europe
12 Oct 2018 //
EMA
Otsuka and Proteus sign 5-year, $88M digital pill partnership
11 Oct 2018 //
FIERCE BIOTECH
Otsuka and Proteus sign 5-year, $88M digital pill partnership
11 Oct 2018 //
FIERCE BIOTECH
Otsuka and Proteus sign 5-year, $88M digital pill partnership
11 Oct 2018 //
FIERCE BIOTECH
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken vs. Amneal Pharma
02 Oct 2018 //
PATENT LITIGATION
Otsuka Pharmaceutical Completes Acquisition of Visterra
04 Sep 2018 //
BUSINESSWIRE
Pharma lacks engagement with mental health groups: report
10 Aug 2018 //
PHARMA TIMES
Otsuka’s $886M-plus drug just flopped in its first crucial PhIII trial for AML
01 Aug 2018 //
ENDPTS
Gamida Cell Expands Leadership Team
23 Jul 2018 //
BUSINESSWIRE
Otsuka has high hopes for its ‘drug creation engine’ acquisition
16 Jul 2018 //
PHARMAPHORUM
Samsca® (tolvaptan): Otsuka Pharmaceutical Co., Ltd., v. Alkem Laboratories Ltd.,
29 Jun 2018 //
PATENT LITIGATION
Medicare alert draws attention to use of laughing drug Nuedexta
04 Jun 2018 //
FIERCE PHARMA
J&J, Macleods in talks for licence deal of tuberculosis drug
12 Mar 2018 //
ECONOMIC TIMES
Akebia shares jump on expanded anemia drug deal with Otsuka
28 Apr 2017 //
BIOSPECTRUM
AKEBIA, OTSUKA ADD TERRITORIES TO VADADUSTAT DEAL
26 Apr 2017 //
BIOCENTURY
AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date
21 Dec 2016 //
NASDAQ
FDA Approves AVANIR New Migraine Treatment With Unique Inhalant Delivery System
01 Feb 2016 //
BIOSPACE
Acucela`s founder wrests back the reins after proxy battle
04 May 2015 //
FIERCE BIOTECH
FDA is Sued by Otsuka for ‘Unlawfully’ Widening the Market for Abilify
26 Mar 2015 //
PHARMALOT